David A Spellman Akebia Therapeutics, Inc. (AKBA) insider trading activity

David A Spellman is SVP, CFO and Treasurer of Akebia Therapeutics, Inc.. Currently has a direct ownership of 446,483 shares of AKBA, which is worth approximately $741,161. The most recent transaction as insider was on May 16, 2023, when has been sold 63,567 shares (Common Stock) at a price of $1.07 per share, resulting in proceeds of $68,016. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 446K

0% 3M change

0% 12M change

Total Value Held $741,161

David A Spellman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2023	SELL Open market or private sale	$68,016 $1.07 p/Share	63,567 Reduced 12.46%	446,483 Common Stock
Mar 01 2023	SELL Open market or private sale	$6,344 $0.88 p/Share	7,210 Reduced 1.39%	510,050 Common Stock
Feb 27 2023	SELL Open market or private sale	$6,106 $0.81 p/Share	7,539 Reduced 1.44%	517,260 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	196,200 Added 27.21%	524,799 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	200,000 Added 37.84%	328,599 Common Stock
Mar 01 2022	SELL Open market or private sale	$1,743 $2.17 p/Share	803 Reduced 0.62%	128,599 Common Stock
Feb 28 2022	SELL Open market or private sale	$15,910 $2.15 p/Share	7,400 Reduced 9.64%	69,402 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	60,000 Added 31.68%	129,402 Common Stock
Apr 01 2021	SELL Open market or private sale	$2,686 $3.4 p/Share	790 Reduced 1.02%	76,802 Common Stock
Mar 16 2021	BUY Grant, award, or other acquisition	-	7,592 Added 8.91%	77,592 Common Stock
Feb 26 2021	BUY Grant, award, or other acquisition	-	70,000 Added 50.0%	70,000 Common Stock

DAS

David A Spellman

SVP, CFO and Treasurer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Value

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Akebia Therapeutics, Inc.

Track Activities on AKBA

Account